| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.47 | 3e-39 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.34 | 1e-20 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.29 | 8e-15 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.38 | 3e-13 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.34 | 7e-12 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-08 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.35 | 5e-08 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0003 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0005 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |